Does the VWF:CB Assay Help to Diagnose von Willebrand Factor Deficiency in Patients With a Bleeding Disorder of Unknown Cause?
- 20 September 2024
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 47 (1) , 149-155
Abstract
Introduction: The entity entitled bleeding disorder of unknown cause (BDUC) qualifies individuals displaying a mild haemorrhagic profile but normal routine coagulation tests. This study was designed to evaluate whether collagen‐binding assay for von Willebrand Factor (VWF) measurement (VWF:CB) could allow to diagnose VW disease in such patients.Methods: A large screening was conducted prospectively in two University Hospitals, using the bleeding assessment tool (BAT) recommended by the International Society of Thrombosis and Hemostasis. Patients with an abnormal BAT were confirmed to have a normal complete hemostatic evaluation. A large range of VWF assays was then carried out on a new blood sample for the 68 individuals (91% women) thus identified. Of note, five VWF:CB using different types of collagen were performed, as well as a comprehensive sequencing of the VWF gene.Results: Of this cohort, only 3 individuals (all blood group O), had a VWF:CB between 40 and 50 IU/dL. No unknown anomaly of the VWF gene was disclosed. Of note, 54% of these patients had unexplained abnormal occlusion times on PFA‐200.Conclusion: This study identified 68 cases of BDUC, after screening of a large population, indicating a low incidence. Only 3 cases were potentially confirmed as displaying moderate von Willebrand disease. VWF:CB tests were globally normal in the 65 other patients of the cohort.Trial Registration: ClinicalTrials.gov identifier: NCT0279220.Keywords
This publication has 13 references indexed in Scilit:
- Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studiesBlood, 2024
- Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis, 2024
- How I treat bleeding disorder of unknown causeBlood, 2021
- Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and managementHaemophilia, 2020
- Common VWF sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWDResearch and Practice in Thrombosis and Haemostasis, 2018
- Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand diseaseAmerican Journal of Hematology, 2016
- Platelet function analyser (PFA‐100) results and von Willebrand factor deficiency: a 16‐year ‘real‐world’ experienceHaemophilia, 2015
- No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variationBlood, 2013
- ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disordersJournal of Thrombosis and Haemostasis, 2010
- Collagen Binding Assay for von Willebrand Factor (VWF:CBA): Detection of von Willebrands Disease (VWD), and Discrimination of VWD Subtypes, Depends on Collagen SourceThrombosis and Haemostasis, 2000